• Nie Znaleziono Wyników

Antihypertensive therapy in stroke secondary prevention

N/A
N/A
Protected

Academic year: 2021

Share "Antihypertensive therapy in stroke secondary prevention"

Copied!
1
0
0

Pełen tekst

(1)

o

rAlPresentAtions

AbstrActs

102

l

Aszlo

c

sibA

Antihypertensive therapy in stroke secondary prevention

Department of Neurology, University Medical School, Debrecen, Hungary

Blood .pressure .is .a .controversial .issue .in .acute .stroke .management . .Patients .with .the .highest .and .lowest .levels .of .blood . pressure in the first day after stroke are more likely to have early neurological decline and poorer outcomes. A low blood pressure .at .stroke .onset .is .unusual . .There .is .no .convincing .evidence .that .active .management .of .blood .pressure .after .acute . stroke influences patient outcomes. Several studies are examining whether blood pressure should be lowered after acute stroke, and whether antihypertensive therapy should be continued or stopped in the first few days after stroke. In patients undergoing .thrombolysis .it .is .common .practice .to .avoid .systolic .blood .pressures .above .185 .mmHg . .

A .meta-analysis .of .seven .randomized .controlled .trials .showed .that .antihypertensive .drugs .reduced .stroke .recurrence . after .stroke .or .TIA . .

Antihypertensive .treatment .is .recommended .for .prevention .of .recurrent .stroke .in .persons .who .have .had .an .ischemic . stroke or TIA and are beyond the acute period. The optimal drug regime remains uncertain: however, the available data support the use of diuretics and the combination of diuretics and ACEI, indefinitely after stroke or TIA. The target BP level and should be individualized, but benefit has been associated with an average reduction of 10/5 mm Hg, and normal BP levels have been defined as <120/80 mmHg.

However, blood pressure should not be lowered intensively in patients with suspected haemodynamic stroke. The angiotensin .receptor .antagonist .eprosartan .may .be .more .effective .than .the .calcium .channel .blocker .nitrendipine . .

G

udrun

b

oysen

Accelerated prophylactic treatment after TIA or mild stroke

Department of Neurology, Bispebjerg Hospital, Copenhagen, Denmark

Within .the .last .years .several .studies .have .shown .that .the .risk .of .stroke .after .transient .ischemic .attack .(TIA) .and .mild . ischemic stroke is much higher within the first days after the event than later on. A score has been developed to define risk of stroke after TIA (Johnston et al, 2007).

Studies from Oxford (Rothwell et al, 2007) and Paris (Lavallée et al, 2007) from 2007 have shown that immediate treatment with platelet inhibition, and a rapid start of statins and blood-pressure treatment reduces the risk of stroke in patients .with .TIA .to .a .level .of .1 .24% .to .2 .1% .within .90 .days . . .These .studies .were .open .with .historical .controls . .

A randomised controlled trial from Canada (FASTER) (Kennedy et al, 2007) was terminated prematurely due to slow recruitment .and .results .were .inconclusive . . .

Establishment .of .open .acute .clinics .for .TIA .patients .is .to .be .considered . . .

referenCes

1. Johnston SC, Rothwell PM, Nguyen-Huynh MN et al. Validation and refinement of scores to predict very early stroke risk after tran-sient .ischaemic .attack . .Lancet .2007; .369: .283-92 . .

2. Rothwell PM, Giles MF, Chandratheva A et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): A prospective population-based sequential comparison. Lancet 2007; 370: 1432-1442. 3. Lavallée PC, Meseguer E, Abboud H et al. A transient ischaemic attack clinic with round-the-clock access /SOS-TIA): feasibility and

effects . .Lancet .Neurol .2007; .:6 .:953-960 . .

4. Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM. Fast assessment of stroke and transient ischaemic attack to .prevent .early .recurrence .(FASTER): .a .randomised .controlled .pilot .trial . .Lancet .Neurol .2007; .6: .961-969 . .

Cytaty

Powiązane dokumenty

1) u chorych po przejœciowym niedokrwieniu mózgu (transient ischemic attack – TIA) lub udarze mózgu niepowoduj¹cym niesprawnoœci, ze znacznego stop- nia zwê¿eniem tszw

Zaburzenia wzrokowo- -przestrzenne były charakterystyczne tylko dla uszkodzeń prawej półkuli móżdżku, natomiast oburęczne spowolnienie i dezorganizacja rucho- wa palców

Do zamierzonych korzyści należą: promowanie właściwego stylu życia, poprawa kondycji fizycznej oraz psychicznej chorego i członków jego rodziny, zwiększenie wiedzy na temat

The aim of the study was to evaluate the prevalence of AF in patients hospitalized due to ischaemic stroke, compare the rates of concomitant conditions in patients with stroke and

Dopiero w badaniach Heart Outcomes Prevention Evaluation Study (HOPE) i PROGRESS, dotyczą- cych terapii hipotensyjnej inhibitorem konwertazy angiotensyny, potwierdzono korzystny

Celem badania Morbidity and mortality after Stro- ke — Eprosartan compared with nitrendypine for Se- condary prevention (MOSES) było porównanie sku- teczności eprosartanu i

Wstęp Liczne badania wykazały, że dobowy profil ciśnienia typu non-dipper lub extreme dipper, duża zmienność ciśnienia, a szczególnie jego wysoki ran- ny wzrost to

The treatment received by patients at discharge better aligned with CARATV2.0 recommendations when warfarin was considered as the first-line therapy, which suggests that